Bill Ackman Wins Two Board Seats At Zoetis

Bill Ackman’s Pershing Square Capital Management LLP won two seats on the board of Zoetis. The announcement comes just two months after the activist investor built a more than 8% stake in the animal health company. Zoetis’ poison pill Last year proved to be Pershing Square’s best year, as Pershing Square Holdings, one of the four hedge funds run by the firm, netted a 40.4% return. Among PSCM’s long positions are Zoetis, Allergan, and Air Products & Chemicals. Bill Ackman first unveiled his investment in Zoetis Inc. in November. Responding to the activist investor’s investment, the animal health company’s board of directors…